Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Apoptosis Regulator BAX

  • Zhiqing Liu
  • Haiying Chen
  • Jia ZhouEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101518


Historical Background

Bax is a proapoptotic protein encoded by Bax gene belonging to B-cell lymphoma 2 (Bcl-2) protein family. Bcl-2 family is classified into two groups: antiapoptotic proteins (e.g., Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1) and proapoptotic proteins according to their different functions. proapoptotic proteins are comprised of multidomain proteins (e.g., Bax and Bak) and BH3-only proteins (e.g., Bid, Bim, Puma, Bad, Noxa, Bik, Bmf, and Hrk) based on the presence of Bcl-2 homology domains (BH1–4 domains) (Liu et al. 2016a, b; Han et al. 2015). Interactions between Bcl-2 protein members regulate the mitochondrial signaling which is critical for normal cellular homeostasis and participates in the pathogenesis of different diseases including cancer, diabetes, obesity, and neurodegenerative disorders.

Bax was originally identified as a heterodimer with Bcl-2 in 1993 (Oltvai et al. 1993). Overexpressed...

This is a preview of subscription content, log in to check access.


  1. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010–4.PubMedCrossRefGoogle Scholar
  2. Czabotar PE, Westphal D, Dewson G, Ma S, Hockings C, Fairlie WD. Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell. 2013;152:519–31.PubMedCrossRefGoogle Scholar
  3. Gavathiotis E, Reyna DE, Davis ML, Bird GH, Walensky LD. BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol Cell. 2010;40:481–92.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Gavathiotis E, Reyna DE, Bellairs JA, Leshchiner ES, Walensky LD. Direct and selective small-molecule activation of proapoptotic BAX. Nat Chem Biol. 2012;8:639–45.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Han B, Park D, Li R, Xie M, Owonikoko TK, Zhang G, Sica GL, Ding C, Zhou J, Magis AT, Chen ZG, Shin DM, Ramalingam SS, Khuri FR, Curran WJ, Deng X. Small-molecule Bcl2 BH4 antagonist for lung cancer therapy. Cancer Cell. 2015;27:852–63.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature. 2006;443:658–62.PubMedCrossRefGoogle Scholar
  7. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 1995;270:96–9.PubMedCrossRefGoogle Scholar
  8. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 2002;111:331–42.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA. Vaccinia virus anti-apoptotic F1 L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 2008;15:1564–71.PubMedCrossRefGoogle Scholar
  10. Liu Z, Ding Y, Ye N, Wild C, Chen H, Zhou J. Direct activation of Bax protein for cancer therapy. Med Res Rev. 2016a;36:313–41.PubMedCrossRefGoogle Scholar
  11. Liu Z, Wild C, Ding Y, Ye N, Chen H, Wold EA. BH4 domain of Bcl-2 as a novel target for cancer therapy. Drug Discov Today. 2016b;21:989–96.PubMedCrossRefGoogle Scholar
  12. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293–9.CrossRefGoogle Scholar
  13. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609–19.PubMedCrossRefGoogle Scholar
  14. Robin AY; Krishna Kumar K; Westphal D; Wardak AZ; Thompson GV; Dewson G; Colman PM; Czabotar PE. Crystal structure of Bax bound to the BH3 peptide of Bim identifies important contacts for interaction. Cell Death Dis. 2015;6:e1809.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science. 2003;300:135–9.PubMedCrossRefGoogle Scholar
  16. Smoot RL, Blechacz BR, Werneburg NW, Bronk SF, Sinicrope FA, Sirica AE. A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells. Cancer Res. 2010;70:1960–9.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Stornaiuolo M, La Regina G, Passacantilli S, Grassia G, Coluccia A, La Pietra V. Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents. J Med Chem. 2015;58:2135–48.PubMedCrossRefGoogle Scholar
  18. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell. 2000;103:645–54.PubMedCrossRefGoogle Scholar
  19. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727–30.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Xin M, Li R, Xie M, Park D, Owonikoko TK, Sica GL, Corsino PE, Zhou J, Ding C, White MA, Magis AT, Ramalingam SS, Curran WJ, Khuri FR, Deng X. Small-molecule Bax agonists for cancer therapy. Nat Commun. 2014;5:4935.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science. 2000;290:989–92.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Zhao G, Zhu Y, Eno CO, Liu Y, Deleeuw L, Burlison JA. Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis. Mol Cell Biol. 2014;34:1198–207.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Chemical Biology Program, Department of Pharmacology and ToxicologyUniversity of Texas Medical BranchGalvestonUSA